Sol-Gel Technologies (SLGL) Selling, General & Administrative (2017 - 2026)
Sol-Gel Technologies (SLGL) posted Selling, General & Administrative of $1.03 million for Q2 2026, down 25.3% from $1.39 million a year earlier and down 12.1% from the prior quarter.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Selling, General & Administrative (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Sol-Gel Technologies was $3.75 million, down 27.8% year-over-year; for FY2025, it came in at $4.18 million, down 27.4% from FY2024.
- Annual Selling, General & Administrative has declined for five consecutive years, with a five-year compound annual growth rate of -17.7% (FY2020 to FY2025).
- In prior years, Sol-Gel Technologies' Selling, General & Administrative was $5.75 million in FY2024 (-22.0%), $7.37 million in FY2023 (-1.0%), $7.45 million in FY2022 (-11.9%) and $8.45 million in FY2021 (-23.8%).
- Quarterly Selling, General & Administrative has run from a low of $577,000 in Q4 2025 to a high of $2.13 million in Q3 2021 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with an average decline of 25.2% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2022, with growth of 14.3%; the weakest was Q4 2025, with a decline of 51.1%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $1.18 million (Q1 2026), $577,000 (Q4 2025) and $957,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Sol-Gel Technologies | 203.39 Mn | 57.80 Mn | - | 1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 957,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 2.13 Mn |
API Access
Sol-Gel Technologies Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();